adplus-dvertising
Connect with us

News

Oilseeds race to reap biofuel bonanza

Published

 on

By Karl Plume and Rod Nickel

ARENZVILLE, Illinois (Reuters) – A disparate group met in an Illinois field on a windy spring morning to study a crop some call stinkweed.

Botanists, businessmen, farmers and federal lawmakers, they all gathered to peer at the waist-high plant usually considered a pest and uprooted on sight because of its foul odor, toxicity and the grim taste it leaves in the milk of grazing cattle.

This was a new version created by gene-editing, though. The compound that made it stinky and poisonous in large doses was suppressed, leaving an oilseed crop that its backers say could help the world transition to a lower-carbon economy via biofuels, as well as meet growing demand for livestock feed.

The group of about 25 people came to survey one of the first large-scale plantings of covercress, the genetically tweaked version of stinkweed, or pennycress.

It is among a handful of crops that could provide alternatives to the world’s most widely used oilseeds, soybeans and canola, crushed to produce oil used in cooking and biofuels, plus high-protein meal for pigs and chickens.

“How often is a brand new oilseed introduced?” Brian Engel, director of biofuels at agribusiness giant Bunge Ltd, told Reuters after visiting the field in Arenzville.

“We’re going to do everything we can to get that seed crushed and get the oil and meal into the marketplace.”

Supplies of soybeans and canola are dwindling rapidly, with not enough produced to keep up with global demand for food and feed products, let alone greener fuels like renewable diesel. Prices have rocketed, contributing to food inflation around the world.

The new candidates, which include carinata and camelina – known as false flax – also represent potential “cover crops”, off-season sources of revenue for farmers to help insulate them from market downturns.

“The solution to this feedstock problem is going to come from a whole lot of sources,” said Jerry Steiner, executive board chairman at startup CoverCress Inc, which is selling the edited stinkweed and has raised $22 million in funding, including from big players like Bayer AG and Bunge.

The company expects plantings of up to 1,000 acres this fall, swelling up to 3 million acres by 2030, saying gene-editing is more accepted by consumers than genetic modification, which introduces new genes.

LOW-CARBON ECONOMY

But it’s early days for the new players.

While demand for oilseeds is rising, it is tough for niche crops to break through as they must meet tough regulatory standards, for biofuels in particular, and be produced at scale to be commercially viable. Scaling up production can take years, requiring financial commitment and risk for both the developers and the farmers who grow the new crops.

Yet the companies behind covercress and carinata spy an opportunity as governments from Canada and California to Europe impose mandates to reduce the carbon-intensity of fuel in an effort to meet stringent climate goals.

Crops like covercress are particularly appealing because they soak up carbon dioxide in the off-season, when fields would otherwise be fallow.

This new reality is putting pressure on refiners to produce fuel from crops instead of fossil fuels and, as a consequence, biofuel demand is forecast to grow exponentially in coming years as more renewable diesel production capacity comes online.

A soaring global appetite for animal feed and vegetable oil has already whittled down stockpiles of soybeans and canola. Farmers say they can’t significantly expand plantings because they must rotate crops to keep soils healthy.

Global supplies of soybeans, by far the world’s most widely used oilseed, are set to hit a five-year low of 86.5 million tonnes by September, while demand is expected to reach a record high, the U.S. Department of Agriculture says. Demand from soybean processors that crush it into oil and meal has swelled 45% over the past decade, while production has grown just 37%.

In the United States, demand for soybean oil could outstrip production by up to 8 billion pounds annually within two years if just half the announced refinery expansion projects are completed, according to BMO Capital Markets.

A consequent surge in prices for soybeans and canola has helped drive the United Nation’s broader food price index to its highest level since 2014, stinging developing countries.

‘IT IS A RARE CROP’

This year, for the first time, Argentine farmer Horacio Merialdo plans to sow carinata, a towering plant crowned with yellow flowers, another new oilseed hoping to make it big.

Merialdo said he would plant carinata in the off-season from growing soybeans, and its deep roots would carve channels that allow rain to seep deep into the soil, and stop weeds flourishing, benefiting the later soybean crops.

He is using seeds supplied by Nuseed, part of Australian agrichemical company Nufarm Ltd, which launched commercial sales last year of carinata in Argentina.

Those plantings are currently less than 100,000 hectares, but the company expects them to double within two years and rise exponentially in subsequent years as it expands production to the United States, Paraguay and Uruguay.

“We experienced the industry repeatedly asking us to go faster, so we’ve ramped up those plans,” said Alex Clayton, Nuseed’s business development lead for carinata.

Yet the perils of plowing his own, experimental furrow are not lost on Merialdo.

“The prospects are good but the risk is that it is a rare crop, with a single price maker and a single buyer,” said Merialdo, who farms in the Pampas grain-belt town of Suipacha, in Buenos Aires province. “So there is less certainty.”

‘I CAN’T PRODUCE ENOUGH’

Nuseed currently sells all carinata production to Saipol, France’s largest biodiesel producer.

Saipol itself is also working on developing new crops, such as the flowering oilseed camelina, to produce biodiesel alongside the fuel it makes largely from rapeseed, a close cousin of canola, said CEO Christophe Beaunoir.

Unlike some new oilseeds like covercress, which have not previously been cultivated, farmers already grow camelina in small quantities for use in fish rations and in health products for dogs and horses.

Smart Earth Seeds, a Canadian seed developer and producer of camelina oil, said the crop was now catching the demand wave lifting soybean and canola prices, more than tripling the company’s sales this year.

“I just can’t produce enough,” CEO Jack Grushcow said.

REFINERS: CAUTIOUS INTEREST

Yet it is a long road for new hopefuls.

“The trick will be whether we can get enough farmers to be interested and comfortable,” CoverCress CEO Mike DeCamp said.

Whole seeds will be sold as poultry feed, with crushing into oil and meal expected to begin in 2025, he added.

Niche crops’ use in biofuels is so far limited. The U.S. Environmental Protection Agency said it was reviewing one fuel facility’s request for approval of carinata as a credit-generating feedstock under the Renewable Fuel Standard. Camelina is already approved.

With production of such oilseeds currently small, refiners are cautious about building plants that rely on them.

Covenant Energy will produce renewable diesel from canola at its planned Saskatchewan refinery, but the facility will also be able to use carinata and camelina, CEO Josh Gustafson said.

Joel MacLeod, CEO of Tidewater Midstream and Infrastructure, is planning to produce 3,000 barrels per day of renewable diesel and renewable hydrogen in total at its refinery in Prince George, British Columbia.

“On camelina and carinata, we definitely have an interest,” he said. “But we can’t have massive swings in our blend, month over month.”

 

(Reporting by Rod Nickel in Winnipeg and Karl Plume in Arenzville, Illinois; additional reporting by Hugh Bronstein in Buenos Aires and Sybille de La Hamaide in Paris; Editing by Caroline Stauffer and Pravin Char)

News

STD epidemic slows as new syphilis and gonorrhea cases fall in US

Published

 on

 

NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday.

The numbers represented some good news about sexually transmitted diseases, which experienced some alarming increases in past years due to declining condom use, inadequate sex education, and reduced testing and treatment when the COVID-19 pandemic hit.

Last year, cases of the most infectious stages of syphilis fell 10% from the year before — the first substantial decline in more than two decades. Gonorrhea cases dropped 7%, marking a second straight year of decline and bringing the number below what it was in 2019.

“I’m encouraged, and it’s been a long time since I felt that way” about the nation’s epidemic of sexually transmitted infections, said the CDC’s Dr. Jonathan Mermin. “Something is working.”

More than 2.4 million cases of syphilis, gonorrhea and chlamydia were diagnosed and reported last year — 1.6 million cases of chlamydia, 600,000 of gonorrhea, and more than 209,000 of syphilis.

Syphilis is a particular concern. For centuries, it was a common but feared infection that could deform the body and end in death. New cases plummeted in the U.S. starting in the 1940s when infection-fighting antibiotics became widely available, and they trended down for a half century after that. By 2002, however, cases began rising again, with men who have sex with other men being disproportionately affected.

The new report found cases of syphilis in their early, most infectious stages dropped 13% among gay and bisexual men. It was the first such drop since the agency began reporting data for that group in the mid-2000s.

However, there was a 12% increase in the rate of cases of unknown- or later-stage syphilis — a reflection of people infected years ago.

Cases of syphilis in newborns, passed on from infected mothers, also rose. There were nearly 4,000 cases, including 279 stillbirths and infant deaths.

“This means pregnant women are not being tested often enough,” said Dr. Jeffrey Klausner, a professor of medicine at the University of Southern California.

What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a “morning-after pill.” Studies have shown that taking doxycycline within 72 hours of unprotected sex cuts the risk of developing syphilis, gonorrhea and chlamydia.

In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men and transgender women who recently had an STD diagnosis. But health departments and organizations in some cities had been giving the pills to people for a couple years.

Some experts believe that the 2022 mpox outbreak — which mainly hit gay and bisexual men — may have had a lingering effect on sexual behavior in 2023, or at least on people’s willingness to get tested when strange sores appeared.

Another factor may have been an increase in the number of health workers testing people for infections, doing contact tracing and connecting people to treatment. Congress gave $1.2 billion to expand the workforce over five years, including $600 million to states, cities and territories that get STD prevention funding from CDC.

Last year had the “most activity with that funding throughout the U.S.,” said David Harvey, executive director of the National Coalition of STD Directors.

However, Congress ended the funds early as a part of last year’s debt ceiling deal, cutting off $400 million. Some people already have lost their jobs, said a spokeswoman for Harvey’s organization.

Still, Harvey said he had reasons for optimism, including the growing use of doxycycline and a push for at-home STD test kits.

Also, there are reasons to think the next presidential administration could get behind STD prevention. In 2019, then-President Donald Trump announced a campaign to “eliminate” the U.S. HIV epidemic by 2030. (Federal health officials later clarified that the actual goal was a huge reduction in new infections — fewer than 3,000 a year.)

There were nearly 32,000 new HIV infections in 2022, the CDC estimates. But a boost in public health funding for HIV could also also help bring down other sexually transmitted infections, experts said.

“When the government puts in resources, puts in money, we see declines in STDs,” Klausner said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Source link

Continue Reading

News

World’s largest active volcano Mauna Loa showed telltale warning signs before erupting in 2022

Published

 on

 

WASHINGTON (AP) — Scientists can’t know precisely when a volcano is about to erupt, but they can sometimes pick up telltale signs.

That happened two years ago with the world’s largest active volcano. About two months before Mauna Loa spewed rivers of glowing orange molten lava, geologists detected small earthquakes nearby and other signs, and they warned residents on Hawaii‘s Big Island.

Now a study of the volcano’s lava confirms their timeline for when the molten rock below was on the move.

“Volcanoes are tricky because we don’t get to watch directly what’s happening inside – we have to look for other signs,” said Erik Klemetti Gonzalez, a volcano expert at Denison University, who was not involved in the study.

Upswelling ground and increased earthquake activity near the volcano resulted from magma rising from lower levels of Earth’s crust to fill chambers beneath the volcano, said Kendra Lynn, a research geologist at the Hawaiian Volcano Observatory and co-author of a new study in Nature Communications.

When pressure was high enough, the magma broke through brittle surface rock and became lava – and the eruption began in late November 2022. Later, researchers collected samples of volcanic rock for analysis.

The chemical makeup of certain crystals within the lava indicated that around 70 days before the eruption, large quantities of molten rock had moved from around 1.9 miles (3 kilometers) to 3 miles (5 kilometers) under the summit to a mile (2 kilometers) or less beneath, the study found. This matched the timeline the geologists had observed with other signs.

The last time Mauna Loa erupted was in 1984. Most of the U.S. volcanoes that scientists consider to be active are found in Hawaii, Alaska and the West Coast.

Worldwide, around 585 volcanoes are considered active.

Scientists can’t predict eruptions, but they can make a “forecast,” said Ben Andrews, who heads the global volcano program at the Smithsonian Institution and who was not involved in the study.

Andrews compared volcano forecasts to weather forecasts – informed “probabilities” that an event will occur. And better data about the past behavior of specific volcanos can help researchers finetune forecasts of future activity, experts say.

(asterisk)We can look for similar patterns in the future and expect that there’s a higher probability of conditions for an eruption happening,” said Klemetti Gonzalez.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

News

Waymo’s robotaxis now open to anyone who wants a driverless ride in Los Angeles

Published

 on

 

Waymo on Tuesday opened its robotaxi service to anyone who wants a ride around Los Angeles, marking another milestone in the evolution of self-driving car technology since the company began as a secret project at Google 15 years ago.

The expansion comes eight months after Waymo began offering rides in Los Angeles to a limited group of passengers chosen from a waiting list that had ballooned to more than 300,000 people. Now, anyone with the Waymo One smartphone app will be able to request a ride around an 80-square-mile (129-square-kilometer) territory spanning the second largest U.S. city.

After Waymo received approval from California regulators to charge for rides 15 months ago, the company initially chose to launch its operations in San Francisco before offering a limited service in Los Angeles.

Before deciding to compete against conventional ride-hailing pioneers Uber and Lyft in California, Waymo unleashed its robotaxis in Phoenix in 2020 and has been steadily extending the reach of its service in that Arizona city ever since.

Driverless rides are proving to be more than just a novelty. Waymo says it now transports more than 50,000 weekly passengers in its robotaxis, a volume of business numbers that helped the company recently raise $5.6 billion from its corporate parent Alphabet and a list of other investors that included venture capital firm Andreesen Horowitz and financial management firm T. Rowe Price.

“Our service has matured quickly and our riders are embracing the many benefits of fully autonomous driving,” Waymo co-CEO Tekedra Mawakana said in a blog post.

Despite its inroads, Waymo is still believed to be losing money. Although Alphabet doesn’t disclose Waymo’s financial results, the robotaxi is a major part of an “Other Bets” division that had suffered an operating loss of $3.3 billion through the first nine months of this year, down from a setback of $4.2 billion at the same time last year.

But Waymo has come a long way since Google began working on self-driving cars in 2009 as part of project “Chauffeur.” Since its 2016 spinoff from Google, Waymo has established itself as the clear leader in a robotaxi industry that’s getting more congested.

Electric auto pioneer Tesla is aiming to launch a rival “Cybercab” service by 2026, although its CEO Elon Musk said he hopes the company can get the required regulatory clearances to operate in Texas and California by next year.

Tesla’s projected timeline for competing against Waymo has been met with skepticism because Musk has made unfulfilled promises about the company’s self-driving car technology for nearly a decade.

Meanwhile, Waymo’s robotaxis have driven more than 20 million fully autonomous miles and provided more than 2 million rides to passengers without encountering a serious accident that resulted in its operations being sidelined.

That safety record is a stark contrast to one of its early rivals, Cruise, a robotaxi service owned by General Motors. Cruise’s California license was suspended last year after one of its driverless cars in San Francisco dragged a jaywalking pedestrian who had been struck by a different car driven by a human.

Cruise is now trying to rebound by joining forces with Uber to make some of its services available next year in U.S. cities that still haven’t been announced. But Waymo also has forged a similar alliance with Uber to dispatch its robotaxi in Atlanta and Austin, Texas next year.

Another robotaxi service, Amazon’s Zoox, is hoping to begin offering driverless rides to the general public in Las Vegas at some point next year before also launching in San Francisco.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending